Over the past 20 years hope has grown around the use of stem cells to enhance regeneration following a heart attack, wherein stem cells would facilitate tissue repair and help restore heart muscle function. However, the legitimacy of cardiac stem cell research is now being called into question.
By Günter Jagschies,GE Healthcare Life Sciences
The biosimilars market is suddenly booming, with established biopharma giants and nimble startups all clamoring for a piece of the action. But such steep competition means that only the wise will survive.